Skip to main content
Device Global Header

Subscribe
or Renew

Advanced Search

This article is available to subscribers. Subscribe now. Already have an account? Sign in

A correction has been published 1

Clinical TherapeuticsFree Preview

Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration

List of authors.
  • James C. Folk, M.D.,
  • and Edwin M. Stone, M.D., Ph.D.

A 66-year-old man presents with a 2-week history of blurred and distorted vision in his right eye. A retinal specialist diagnoses neovascular age-related macular degeneration (AMD) and recommends treatment with ranibizumab.

Continue reading this article

Select an option below:

Create your account to get 2 free subscriber-only articles each month.

Get Free Access Now Subscribe For Full Access

Already have an account?

Sign In

Print subscriber?

Activate your online access.

Funding and Disclosures

Supported by the Robert C. Watzke Research Fund, Research to Prevent Blindness, the Foundation Fighting Blindness, a grant (EY016822) from the National Eye Institute, and the Howard Hughes Medical Institute.

Disclosure forms provided by the authors are available with the full text of this article at NEJM.org.

No potential conflict of interest relevant to this article was reported.

We thank Robert F. Mullins, Ph.D., for his critical review and advice; Alton Szeto Illustration for the drawings that served as the design for Figure 2; and Patricia Duffel for her reference help.

Author Affiliations

From the Department of Ophthalmology and Visual Sciences (J.C.F., E.M.S.) and the Howard Hughes Medical Institute (E.M.S.), University of Iowa Carver College of Medicine, Iowa City.

Address reprint requests to Dr. Stone at the Department of Ophthalmology and Visual Sciences, University of Iowa, 375 Newton Rd., 4111 MERF, Iowa City, IA 52242, or at .

Print Subscriber? Activate your online access.